Literature DB >> 22936324

Analysis on interrelation between electroacupuncture-induced cumulative analgesic effect and hypothalamic cholinergic activities in chronic neuropathic pain rats.

Jun-Ying Wang1, Fan-Ying Meng, Shu-Ping Chen, Yong-Hui Gao, Jun-Ling Liu.   

Abstract

OBJECTIVE: To observe the effects of repeated electroacupuncture (EA) of Zusanli (ST36)- Yanglingquan (GB34) on hypothalamic acetylcholinesterase (AchE) and vesicular acetylcholine (ACh) transporter (VAChT) activities and choline acetyltransferase (ChAT) mRNA and muscarinic M1 receptor (M1R) mRNA expression in chronic constrictive injury (CCI) and/or ovariectomy (OVX) rats so as to reveal its underlying mechanism in cumulative analgesia.
METHODS: A total of 103 female Wistar rats were randomly divided into normal control (n =15), CCI (n =15), CCI+EA2d (n =15), CCI+EA2W (n =15), OVX+CCI =13), OVX+CCI+EA2d (n =15), and OVX+CCI+EA2W groups (n =15). CCI model was established by ligature of the unilateral sciatic nerve with surgical suture. Memory impairment model was established by removal of the bilateral ovaries. Morris water test was conducted to evaluate the OVX rats' memory learning ability, and the thermal pain threshold (PT) of the bilateral paws was detected the next morning after EA. EA (2/15 Hz, 1 mA) was applied to bilateral ST36-GB34 for 30 min, once daily for 2 days or 2 weeks, respectively. Hypothalamic AChE activity was detected by histochemistry, VAChT immunoactivity was determined by immunohistochemistry, and ChAT mRNA and M1R mRNA expressions were assayed by reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: In comparison with the normal control group, the AChE activity in hypothalamic arcuate nucleus (ARC) and supraoptic nucleus (SON) regions of CCI group, AChE activity in paraventricular nucleus (PVN), ARC, and SON regions of OVX+CCI group, and hypothalamic muscarinic M1R mRNA expression levels in both CCI and OVX+CCI groups were down-regulated significantly (P <0.05). Compared with the CCI group, the AChE activities in hypothalamic ARC and SON regions of CCI+EA2d and CCI+EA2W groups and PVN region of CCI+EA2W group and hypothalamic ChAT mRNA and M1R mRNA expression levels in CCI+EA2W group were up-regulated considerably (P <0.05). In comparison with the OVX+CCI group, the AChE activities in PVN, ARC, and SON regions and the expressions of hypothalamic ChAT mRNA and VAChT in ARC region of OVX+CCI+EA2W group were up-regulated remarkably (P <0.05). The effects in rats of CCI+EA2W group were evidently superior to those of OVX+CCI+EA2d group in up-regulating AChE activities in PVN, ARC, and SON regions, VAChT immunoactivity in ARC region, and expression levels of hypothalamic ChAT mRNA and M1R mRNA (P <0.05). Similar situations were found in OVX+CCI rats after EA2W. It suggested a cumulative effect after repeated EA of ST36-GB34. Comparison between CCI+EA2W and OVX+CCI+EA2W groups showed that the effects in rats of the former group were evidently better than those of the latter group in up-regulating AChE activity in ARC and SON regions and the expressions of hypothalamic ChAT mRNA and M1 mRNA (P <0.05), suggesting a reduction of EA2W effects after OVX.
CONCLUSION: Repeated EA can significantly up-regulate AChE and VAChT activities and ChAT mRNA and M1R mRNA expressions in the hypothalamus of CCI and OVX+CCI rats, which may contribute to the cumulative analgesic effects of repeated EA and be closely related to the animals' neuromemory ability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936324     DOI: 10.1007/s11655-012-1059-1

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  31 in total

1.  Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

2.  [The neurobiology of pain].

Authors:  Per Brodal
Journal:  Tidsskr Nor Laegeforen       Date:  2005-09-08

3.  Analgesic effect of electroacupuncture on inflammatory pain in the rat model of collagen-induced arthritis: mediation by cholinergic and serotonergic receptors.

Authors:  Yong Hyeon Baek; Do Young Choi; Hyung In Yang; Dong Suk Park
Journal:  Brain Res       Date:  2005-09-28       Impact factor: 3.252

4.  Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.

Authors:  I M Khan; T L Yaksh; P Taylor
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

5.  Scopolamine into the anterior cingulate cortex diminishes nociception in a neuropathic pain model in the rat: an interruption of 'nociception-related memory acquisition'?

Authors:  J Manuel Ortega-Legaspi; Alberto López-Avila; Ulises Coffeen; Rosendo del Angel; Francisco Pellicer
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

6.  Distribution and morphological characteristics of acetylcholinesterase-containing neurons in the basal forebrain of the cat.

Authors:  A Parent; J O'Reilly-Fromentin
Journal:  Brain Res Bull       Date:  1982-02       Impact factor: 4.077

7.  Time-dependent alterations of cholinergic markers after experimental traumatic brain injury.

Authors:  Cornelius K Donat; Martin U Schuhmann; Cornelia Voigt; Karen Nieber; Winnie Deuther-Conrad; Peter Brust
Journal:  Brain Res       Date:  2008-09-30       Impact factor: 3.252

8.  Chronic systemic injection of D-galactose impairs the septohippocampal cholinergic system in rats.

Authors:  Ming Lei; Yang Su; Xiangdong Hua; Jiong Ding; Qunying Han; Gang Hu; Ming Xiao
Journal:  Neuroreport       Date:  2008-10-29       Impact factor: 1.837

Review 9.  Nociceptive behavior in animal models for peripheral neuropathy: spinal and supraspinal mechanisms.

Authors:  Nayef E Saadé; Suhayl J Jabbur
Journal:  Prog Neurobiol       Date:  2008-06-18       Impact factor: 11.685

10.  [Observation on the accumulative analgesic effect of electroacupuncture and the expression of protein kinase A in hypothalamus and hippocampus in chronic pain or/and ovariectomized rats].

Authors:  Jun-Ying Wang; Shu-Ping Chen; Yan-Hua Li; Fan-Ying Meng; Yong-Hui Gao; Jun-Ling Liu
Journal:  Zhen Ci Yan Jiu       Date:  2008-04
View more
  6 in total

1.  Acupuncture: Emerging evidence for its use as an analgesic (Review).

Authors:  Peng Gao; X I Gao; Tairan Fu; Dan Xu; Qingping Wen
Journal:  Exp Ther Med       Date:  2015-03-12       Impact factor: 2.447

2.  Effect of Repeated Electroacupuncture Intervention on Hippocampal ERK and p38MAPK Signaling in Neuropathic Pain Rats.

Authors:  Jun-Ying Wang; Shu-Ping Chen; Yong-Hui Gao; Li-Na Qiao; Jian-Liang Zhang; Jun-Ling Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-16       Impact factor: 2.629

3.  Effect of electroacupuncture on the expression of agrin and acetylcholine receptor subtypes in rats with tibialis anterior muscular atrophy induced by sciatic nerve injection injury.

Authors:  Jianqi Yu; Meng Wang; Junying Liu; Xiaoming Zhang; Shengbo Yang
Journal:  Acupunct Med       Date:  2017-01-09       Impact factor: 2.267

4.  Electroacupuncture Alleviates Pain-Related Emotion by Upregulating the Expression of NPS and Its Receptor NPSR in the Anterior Cingulate Cortex and Hypothalamus.

Authors:  Zitong Xu; JunFan Fang; Xuaner Xiang; HaiJu Sun; SiSi Wang; Jianqiao Fang; Junying Du
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-10       Impact factor: 2.629

5.  Involvement of hippocampal acetylcholinergic receptors in electroacupuncture analgesia in neuropathic pain rats.

Authors:  Shu Ping Chen; Yu Kan; Jian Liang Zhang; Jun Ying Wang; Yong Hui Gao; Li Na Qiao; Xiu Mei Feng; Ya Xia Yan; Jun Ling Liu
Journal:  Behav Brain Funct       Date:  2016-04-12       Impact factor: 3.759

6.  Involvement of spinal muscarinic and serotonergic receptors in the anti-allodynic effect of electroacupuncture in rats with oxaliplatin-induced neuropathic pain.

Authors:  Ji Hwan Lee; Donghyun Go; Woojin Kim; Giseog Lee; Hyojeong Bae; Fu Shi Quan; Sun Kwang Kim
Journal:  Korean J Physiol Pharmacol       Date:  2016-06-23       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.